Literature DB >> 30397856

Radio-pathological Correlation of 18F-FDG PET in Characterizing Gallbladder Wall Thickening.

Vikas Gupta1, K S Vishnu2, Thakur D Yadav2, Yashwant R Sakaray2, Santosh Irrinki2, B R Mittal3, N Kalra4, K Vaiphei5.   

Abstract

AIM: Thick-walled gallbladder is difficult to characterize on conventional imaging. 18F-FDG PET was used to differentiate benign and malignant wall thickness and compared with histopathology.
METHODS: Thirty patients with gallbladder (GB) wall thickening (focal > 4 mm and diffuse > 7 mm), underwents uspected on  ultrasound, or CT scan, and underwent 18F-FDG PET. Histopathology of the specimen was compared with imaging findings.
RESULTS: The mean age was 48.22 ± 31.33 years with a M:F 1:4 ratio. Twenty patients had diffuse and 10 had focal thickening. On 18F-FDG PET, lesion was benign in 12, malignant in 13, and indeterminate in 5. Histopathology was malignancy in 12; benign in 18-chronic cholecystitis in 11, xanthogranulomatous in 4, IgG4 related in 2, and polyp in 1. The mean GB wall thickness was 7.79 ± 3.59 mm (10.34 malignant and 6.10 in benign, p = 0.001). At a cutoff of 8.5 mm, the sensitivity and specificity of detecting malignancy was 94% and 67%. The mean SUV uptake was 7.46 (benign 4.51, malignant 14.26, p = 0.0102). At a cutoff of 5.95, the sensitivity and specificity of detecting malignancy was 92% and 79%. For 18F-FDG PET, overall sensitivity was 91%, specificity 79%, PPV 77%, NPV 92%, and diagnostic accuracy was 84%.
CONCLUSION: 18F-FDG PET is a reliable method of differentiation between benign and malignant thickening of the gallbladder particularly when wall thickness and SUV value is taken into account.

Entities:  

Keywords:  Cancer; Cholecystitis; Gall badder; PET CT; Thickening; Xanthogranulomatous

Mesh:

Substances:

Year:  2019        PMID: 30397856     DOI: 10.1007/s12029-018-0176-2

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  23 in total

1.  Analysis of enhancement pattern of flat gallbladder wall thickening on MDCT to differentiate gallbladder cancer from cholecystitis.

Authors:  Soo Jin Kim; Jeong Min Lee; Jae Young Lee; Se Hyung Kim; Joon Koo Han; Byung Ihn Choi; Jin Young Choi
Journal:  AJR Am J Roentgenol       Date:  2008-09       Impact factor: 3.959

2.  Diagnostic nomogram for gallbladder wall thickening mimicking malignancy: using contrast-enhanced ultrasonography or multi-detector computed tomography?

Authors:  Li-Da Chen; Yang Huang; Xiao-Hua Xie; Wei Chen; Quan-Yuan Shan; Ming Xu; Jin-Ya Liu; Zhi-Qiang Nie; Xiao-Yan Xie; Ming-De Lu; Shun-Li Shen; Wei Wang
Journal:  Abdom Radiol (NY)       Date:  2017-10

3.  Distinguishing benign from malignant gallbladder wall thickening using FDG-PET.

Authors:  Ai Oe; Joji Kawabe; Kenji Torii; Etsushi Kawamura; Shigeaki Higashiyama; Jin Kotani; Takehiro Hayashi; Hiroko Kurooka; Chikako Tsumoto; Shoji Kubo; Susumu Shiomi
Journal:  Ann Nucl Med       Date:  2006-12       Impact factor: 2.668

4.  Xanthogranulomatous cholecystitis: differentiation from associated gall bladder carcinoma.

Authors:  R V Raghavendra Rao; Ashok Kumar; Sadiq S Sikora; Rajan Saxena; Vinay K Kapoor
Journal:  Trop Gastroenterol       Date:  2005 Jan-Mar

5.  Dual-time-point 18F-FDG PET for the evaluation of gallbladder carcinoma.

Authors:  Yoshihiro Nishiyama; Yuka Yamamoto; Kotaro Fukunaga; Naruhide Kimura; Akihiro Miki; Yasuhiro Sasakawa; Hisao Wakabayashi; Katashi Satoh; Motoomi Ohkawa
Journal:  J Nucl Med       Date:  2006-04       Impact factor: 10.057

6.  Positron-emission tomography with fluorine-18-fluoro-2-deoxy-D-glucose for gallbladder cancer diagnosis.

Authors:  Antonio Rodríguez-Fernández; Manuel Gómez-Río; José Manuel Llamas-Elvira; Simeón Ortega-Lozano; Jose Antonio Ferrón-Orihuela; Jose Manuel Ramia-Angel; Alfonso Mansilla-Roselló; María Dolores Martínez-del-Valle; Carlos Ramos-Font
Journal:  Am J Surg       Date:  2004-08       Impact factor: 2.565

7.  Anticipatory extended cholecystectomy: the 'Lucknow' approach for thick walled gall bladder with low suspicion of cancer.

Authors:  Vinay K Kapoor; Rakesh Singh; Anu Behari; Supriya Sharma; Ashok Kumar; Anand Prakash; Rajneesh Kumar Singh; Ashok Kumar; Rajan Saxena
Journal:  Chin Clin Oncol       Date:  2016-02

8.  Prognostic Value of SUVmax Measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Gallbladder Cancer.

Authors:  Jae Pil Hwang; Ilhan Lim; Im Ii Na; Eung Ho Cho; Byung Ii Kim; Chang Woon Choi; Sang Moo Lim
Journal:  Nucl Med Mol Imaging       Date:  2013-12-06

9.  Computed Tomography (CT) and Magnetic Resonance (MR) Findings in Xanthogranulomatous Cholecystitis: Retrospective Analysis of Pathologically Proven 30 Cases - Tertiary Care Experience.

Authors:  Binit Sureka; Vaibhav Pratap Singh; S Rajesh Rajesh; Shalini Laroia; Kalpana Bansal; Archana Rastogi; Chhagan Bihari; Ajeet Singh Bhadoria; Nikhil Agrawal; Asit Arora
Journal:  Pol J Radiol       Date:  2017-06-22

10.  Role of Multidetector Computed Tomography (MDCT) in Evaluation of Gallbladder Malignancy and its Pathological Correlation in an Indian Rural Center.

Authors:  Gunjan Jindal; Samita Singal; Birinder Nagi; Amit Mittal; Shallini Mittal; Rikki Singal
Journal:  Maedica (Bucur)       Date:  2018-03
View more
  5 in total

Review 1.  Imaging-based algorithmic approach to gallbladder wall thickening.

Authors:  Pankaj Gupta; Yashi Marodia; Akash Bansal; Naveen Kalra; Praveen Kumar-M; Vishal Sharma; Usha Dutta; Manavjit Singh Sandhu
Journal:  World J Gastroenterol       Date:  2020-10-28       Impact factor: 5.742

2.  Carcinosarcoma of gallbladder: A world review.

Authors:  Thomas Zheng Jie Teng; Branden Qi Yu Chua; Vishal G Shelat
Journal:  World J Clin Oncol       Date:  2021-12-24

3.  Asymptomatic chronic suppurative cholecystitis and peritonitis mimicking metastasis by 18F-FDG PET/CT scan during sigmoid colon cancer surveillance.

Authors:  Yanqin Sun; MingMing Yu; DaCheng Li; LingLing Sun; Zhenguang Wang
Journal:  BJR Case Rep       Date:  2021-07-21

4.  Clinical and metabolic parameters for predicting disease progression of gallbladder adenocarcinoma.

Authors:  Yeon-Hee Han; Hwan-Jeong Jeong; Seok Tae Lim
Journal:  Nucl Med Commun       Date:  2022-01-01       Impact factor: 1.698

5.  Management and follow-up of gallbladder polyps: updated joint guidelines between the ESGAR, EAES, EFISDS and ESGE.

Authors:  Kieran G Foley; Max J Lahaye; Ruedi F Thoeni; Marek Soltes; Catherine Dewhurst; Sorin Traian Barbu; Yogesh K Vashist; Søren Rafael Rafaelsen; Marianna Arvanitakis; Julie Perinel; Rebecca Wiles; Stuart Ashley Roberts
Journal:  Eur Radiol       Date:  2021-12-17       Impact factor: 7.034

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.